On Monday a district judge in Massachusetts declared the Trump administration’s squashing of billions in NIH grants “void and illegal.” 

Lines included in the kits were misassembled and could result in a botched blood transfusion. Due to the risk of serious injury or death, the recall has been designated as Class I.

Endotracheal tubes inside Medline neonatal intubation kits have been deemed too narrow, putting newborn patients at risk for hypoxia. This recall has been given the most serious FDA designation due to the risk of death.

Law firm Wright & Schulte said they filed a legal complaint on behalf of patients, pointing to the health system’s alleged lack of transparency and negligence in protecting data as the basis for the lawsuit.

Researchers at Cybernews said they discovered a database online containing patient names, contact information and appointment records from millions of patients who received dental care. No one has claimed the database. However, clues point to it belonging to Gargle, an industry marketing group. 

Some infusion systems manufactured by Zyno Medical were released with unapproved software that could cause safety features to malfunction. Use of any device subject to the recall is to cease immediately. 

The exact number of rehires is unclear. However, the move marks the largest number of workers returning to the Centers for Disease Control and Prevention since the agency was targeted for firings by Elon Musk's DOGE.

A lack of Medicare reimbursement is just one issue. In a national survey, home healthcare agencies report dropping telemedicine offerings because elderly patients tend to prefer in-person care. 

This is the second time Mark Linskey, MD, has been awarded a judgement. He claims UC Irvine kicked him out of a residency program when he reported patient safety concerns and multiple incidents of waste at the academic health system. 

Radiology advocates on Monday said they were "deeply disappointed" with the decision while emphasizing it is still early in the process. 

Janet Wei, MD, examined the key differences between men and women when it comes to cardiovascular disease. These differences, she said, highlight why female patients need their very own treatment guidelines.